Neuberg Supratech Reference Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.50 M
as on 17-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 58.41 Cr
as on 17-12-2024
- Revenue 32.48%
(FY 2022)
- Profit -38.38%
(FY 2022)
- Ebitda -28.70%
(FY 2022)
- Net Worth 40.35%
(FY 2022)
- Total Assets 56.93%
(FY 2022)
About Neuberg Supratech Reference Laboratories
- CIN/LLPIN
U85195TN2013PTC151947
- Company No.
077365
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2013
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neuberg Supratech Reference Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavini Shah  | Director | 29-Oct-2013 | Current |
| Gomathy Kulandaivelu | Director | 03-May-2018 | Current |
| Athmanathan Ganesan | Director | 03-May-2018 | Current |
| Sandip Shah | Director | 29-Oct-2013 | Current |
Financial Performance of Neuberg Supratech Reference Laboratories.
Neuberg Supratech Reference Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.48% increase. The company also saw a substantial fall in profitability, with a 38.38% decrease in profit. The company's net worth Soared by an impressive increase of 40.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg Supratech Reference Laboratories?
In 2022, Neuberg Supratech Reference Laboratories had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedActive 4 years 7 monthsGomathy Kulandaivelu, Athmanathan Ganesan and 1 more are mutual person
Nasmed Diagnostic Private LimitedActive 2 years 11 monthsSandip Shah and Bhavini Shah are mutual person
Magnum Imaging & Diagnostics Private LimitedActive 11 years 3 monthsAthmanathan Ganesan is a mutual person
Neuberg Supratech Rajkot Private LimitedActive 6 years 3 monthsSandip Shah and Bhavini Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jul 2021 | ₹25.50 Cr | Satisfied |
Others Creation Date: 07 Jun 2021 | ₹22.50 Cr | Satisfied |
Others Creation Date: 07 Apr 2017 | ₹8.30 M | Satisfied |
How Many Employees Work at Neuberg Supratech Reference Laboratories?
Neuberg Supratech Reference Laboratories has a workforce of 868 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg Supratech Reference Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Supratech Reference Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
